Birmingham has a much higher than average number of asthma sufferers. This condition has been traced to the high levels of soot pollution that are allowed to exist in Birmingham.
The majority of people that suffer from asthma use inhaled glucocorticoids to relieve the breathlessness that occurs randomly with this disease.
New research published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine have determined that the use of inhaled glucocorticoids by women that are pregnant can have an adverse affect on their child’s chances of developing endocrine and metabolic disorders.
The research was based on an examination of 65,085 mother-child pairs from the Danish National Birth Cohort. The chances are that almost 80 percent of children whose mothers used an inhaled glucocorticoid to treat asthma will develop some type of endocrine and metabolic disorder by age 6.
The effect of the disorder rate is dependent on the frequency of use of the inhaled glucocorticoids.
There are options to inhaled glucocorticoids for the treatment of asthma symptoms that have not been shown to produce adverse affects on a child's health.
This is the first study to examine the relationship between asthma drugs and the health of children whose mothers used the drugs while pregnant.
Marion Tegethoff, Ph.D., associate faculty member in clinical psychology and psychiatry at the University of Basel, Switzerland and Gunther Meinlschmidt, Ph.D., associate faculty member in clinical psychology and epidemiology at the University of Basel, Switzerland were responsible for the analysis that was reported at the Eureka Alert web site on December 16, 2011.
Comments